From The Independent:
‘Trojan horse’ cancer drug can extend survival where other treatments fail, trials show
A cancer drug which uses an unprecedented “Trojan horse” approach to destroy tumours from the inside has shown promising results across six different forms of the disease.
UK researchers have hailed the results from early human tests of the drug, known as tisotumab vedotin (TV), after it stopped or shrank tumours in patients with no other options left.
The treatment combines a cancer-killing chemotherapy agent with an antibody, a biological molecule which binds to markers on the surface of cancer cells and causes the drug to be drawn inside.